Geode Capital Management, LLC Uro Gen Pharma Ltd. Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Geode Capital Management, LLC holds 455,637 shares of URGN stock, worth $5.03 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

455,637

Previous 421,389 8.13%

Holding current value

$5.03 Million

Previous $7.07 Million 18.16%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$12.7 - $17.92 $434,949 - $613,724	34,248 Added 8.13%	455,637 $5.79 Million
Q2 2024 Aug 09, 2024	BUY	$12.72 - $19.2 $1.24 Million - $1.87 Million	97,437 Added 30.08%	421,389 $7.07 Million
Q1 2024 May 13, 2024	BUY	$13.81 - $19.33 $157,931 - $221,057	11,436 Added 3.66%	323,952 $4.86 Million
Q4 2023 Feb 13, 2024	BUY	$10.87 - $15.93 $1.02 Million - $1.49 Million	93,389 Added 42.62%	312,516 $4.69 Million
Q3 2023 Nov 13, 2023	BUY	$8.84 - $22.64 $153,869 - $394,071	17,406 Added 8.63%	219,127 $3.07 Million
Q2 2023 Aug 11, 2023	BUY	$8.75 - $14.29 $1.64 Million - $2.68 Million	187,345 Added 1303.18%	201,721 $2.09 Million
Q2 2022 Aug 12, 2022	SELL	$5.12 - $8.74 $828,605 - $1.41 Million	-161,837 Reduced 91.84%	14,376 $117,000
Q1 2022 May 13, 2022	BUY	$5.92 - $9.73 $50,059 - $82,276	8,456 Added 5.04%	176,213 $1.53 Million
Q4 2021 Feb 11, 2022	BUY	$9.03 - $19.13 $122,555 - $259,632	13,572 Added 8.8%	167,757 $1.6 Million
Q3 2021 Nov 12, 2021	SELL	$14.31 - $18.39 $163,277 - $209,829	-11,410 Reduced 6.89%	154,185 $2.59 Million
Q2 2021 Aug 13, 2021	BUY	$15.2 - $20.94 $6,536 - $9,004	430 Added 0.26%	165,595 $2.53 Million
Q1 2021 May 12, 2021	BUY	$17.99 - $26.96 $333,228 - $499,380	18,523 Added 12.63%	165,165 $3.22 Million
Q4 2020 Feb 12, 2021	SELL	$17.54 - $25.43 $34,431 - $49,919	-1,963 Reduced 1.32%	146,642 $2.64 Million
Q3 2020 Nov 13, 2020	SELL	$18.81 - $26.42 $5,868 - $8,243	-312 Reduced 0.21%	148,605 $2.87 Million
Q2 2020 Aug 13, 2020	BUY	$16.5 - $29.7 $186,978 - $336,560	11,332 Added 8.24%	148,917 $3.89 Million
Q1 2020 May 14, 2020	BUY	$13.68 - $34.6 $205,760 - $520,418	15,041 Added 12.27%	137,585 $2.45 Million
Q4 2019 Feb 13, 2020	BUY	$21.11 - $34.86 $269,785 - $445,510	12,780 Added 11.64%	122,544 $4.09 Million
Q3 2019 Nov 12, 2019	BUY	$23.83 - $36.44 $136,164 - $208,218	5,714 Added 5.49%	109,764 $2.62 Million
Q2 2019 Aug 14, 2019	BUY	$32.75 - $40.35 $2.9 Million - $3.57 Million	88,475 Added 568.06%	104,050 $3.74 Million
Q1 2019 May 14, 2019	BUY	$35.47 - $54.55 $264,251 - $406,397	7,450 Added 91.69%	15,575 $575,000
Q3 2018 Nov 13, 2018	BUY	$41.65 - $51.7 $40,817 - $50,666	980 Added 13.72%	8,125 $383,000
Q3 2017 Nov 14, 2017	BUY	$17.15 - $32.72 $122,536 - $233,784	7,145	7,145 $225,000

Others Institutions Holding URGN

# of Institutions

130

Shares Held

35.9M

Call Options Held

22K

Put Options Held

93.8K

View Full List

About UroGen Pharma Ltd.

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $251M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

More about URGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Uro Gen Pharma Ltd. Transaction History